Hypertension and Sleep Apnea

Canadian Journal of Cardiology

Volumn 31, Issue 7, 2015, Pages 889-897

  Floras, John S ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT;

APNEA HYPOPNEA INDEX; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); DRUG RESISTANT HYPERTENSION; GENE EXPRESSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; HYPERTENSION; KIDNEY VASCULAR RESISTANCE; LUNG VOLUME; META ANALYSIS (TOPIC); OSCILLATION; OXYGEN CONSUMPTION; OXYGEN DESATURATION; OXYGEN SATURATION; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REM SLEEP; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLEEP DISORDERED BREATHING; BLOOD PRESSURE; COMPLICATION; HEALTH; MORBIDITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SLEEP APNEA SYNDROMES; TRENDS;

BLOOD PRESSURE; GLOBAL HEALTH; HUMANS; HYPERTENSION; MORBIDITY; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 84937575044     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.05.003     Document Type: Review

References (103)

1. Somers V.K., Dyken M.E., Mark A.L., Abboud F.M. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993, 328:303-307.
2. Vanoli E., Adamson P.B., Ba-Lin, et al. Heart rate variability during specific sleep stages. A comparison of healthy subjects with patients after myocarial infarction. Circulation 1995, 91:1918-1922.
3. Hossmann V., Fitzgerald G.A., Dollery C.T. Circadian rhythm of baroreflex reactivity and adrenergic vascular response. Cardiovasc Res 1980, 14:125-129.
4. Floras J.S., Jones J.V., Johnston J.A., et al. Arousal and the circadian rhythm of blood pressure. Clin Sci Mol Med Suppl 1978, 4:395s-397s.
5. Floras J.S., Sleight P. Ambulatory monitoring of blood pressure. Scientific Foundations of Cardiology 1983, 155-164. Heineman, London. P. Sleight, J.V. Jones (Eds.).
6. Young M.E. The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am J Physiol Heart Circ Physiol 2006, 290:H1-H16.
7. Young M.E., Razeghi P., Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 2001, 88:1142-1150.
8. Young M.E., Razeghi P., Cedars A.M., Guthrie P.H., Taegtmeyer H. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 2001, 89:1199-1208.
9. Martino T.A., Sole M.J. Molecular time: an often overlooked dimension to cardiovascular disease. Circ Res 2009, 105:1047-1061.
10. Alibhai F.J., Tsimakouridze E.V., Chinnappareddy N., et al. Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function. Circ Res 2014, 114:1713-1722.
11. Fan H.Q., Li Y., Thijs L., et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010, 28:2036-2045.
12. Dolan E., Stanton A., Thijs L., et al. Superiority of ambulatory over clinic blood pressure in predicting mortality. Hypertension 2005, 46:156-161.
13. Boggia J., Thijs L., Hansen T.W., et al. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension 2011, 57:397-405.
14. Draman MS, Dolan E, van der Poel L, et al. The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study. J Hypertens 2015;33:1373-7.
15. Bradley T.D., Floras J.S. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 2003, 107:1671-1678.
16. Classification of OSA according to AHI. Sleep 1999, 22:667-689. American Academy of Sleep Medicine Task Force.
17. Kasai T., Floras J.S., Bradley T.D. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012, 126:1495-1510.
18. Jordan A.S., McSharry D.G., Malhotra A. Adult obstructive sleep apnoea. Lancet 2014, 383:736-747.
19. Bradley T.D., Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009, 373:82-93.
20. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
21. Punjabi N.M., Caffo B.S., Goodwin J.L., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.
22. Young T., Finn L., Peppard P.E., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31:1071-1078.
23. Kendzerska T., Gershon A.S., Hawker G., Leung R.S., Tomlinson G. Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med 2014, 11:e1001599.
24. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observation study. Lancet 2005, 365:1046-1053.
25. Campos-Rodriguez F., Martinez-Garcia M.A., de la Cruz-Moron I., et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012, 156:115-122.
26. Loke Y.K., Brown J.W., Kwok C.S., Niruban A., Myint P.K. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2012, 5:720-728.
27. Gami A.S., Olson E.J., Shen W.K., et al. Obstructive sleep apnea and the risk of sudden cardiac death. J Am Coll Cardiol 2013, 62:610-616.
28. Gottlieb D.J., Yenokyan G., Newman A.B., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
29. Somers V.K., White D.P., Amin R., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. Circulation 2008, 118:1080-1111.
30. Young T., Palta M., Dempsey J., et al. The occurence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
31. Peppard P.E., Young T., Barnet J.H., et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013, 177:1006-1014.
32. Arzt M., Young T., Finn L., et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006, 166:1716-1722.
33. Taranto Montemurro L., Floras J.S., Millar P.J., et al. Inverse relationship of subjective daytime sleepiness to sympathetic activity in patients with heart failure and obstructive sleep apnea. Chest 2012, 142:1222-1228.
34. Seif F., Patel S.R., Walia H.K., et al. Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk. J Hypertens 2014, 32:267-275.
35. Kario K. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure. Hypertens Res 2009, 32:428-432.
36. Suzuki M., Guilleminault C., Otsuka K., Shiomi T. Blood pressure "dipping" and "non-dipping" in obstructive sleep apnea syndrome patients. Sleep 1996, 19:382-387.
37. Spaak J., Egri Z.J., Kubo T., et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005, 46:1327-1332.
38. Usui K., Bradley T.D., Spaak J., et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005, 45:2008-2011.
39. Floras J.S. Should sleep apnoea be a specific target of therapy in chronic heart failure?. Heart 2009, 95:1041-1046.
40. Floras J.S. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 2009, 54:375-385.
41. Kimmerly D.S., Morris B.L., Floras J.S. Apnea-induced cortical BOLD-fMRI and peripheral sympathoneural firing response patterns of awake healthy humans. PLoS One 2013, 8:e82525.
42. Grassi G., Facchini A., Quarti F., et al. Obstructive sleep apnea - dependent and - independent adrenergic activation in obesity. Hypertension 2005, 46:321-325.
43. Grassi G., Seravalle G., Quarti-Trevano F., et al. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 2009, 53:205-209.
44. Sin D.D., Fitzgerald F., Parker J.D., et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 2003, 123:1536-1543.
45. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348:1233-1241.
46. DiBona G.F. Physiology in perspective: the wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 2005, 289:R633-R641.
47. Pratt-Ubunama M.N., Nishizaka M.K., Boedefeld R.L., et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007, 131:453-459.
48. Redolfi S., Yumino D., Ruttanaumpawan P., et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009, 179:241-246.
49. Gaddam K., Pimenta E., Thomas S.J., et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2010, 24:532-537.
50. Jelic S., Lederer D.J., Adams T., et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010, 121:1014-1021.
51. Millar P.J., Murai H., Floras J.S. Neurogenic retrograde arterial flow during obstructive sleep apnea: a novel mechanism for endothelial dysfunction?. Hypertension 2011, 58:e17-e18.
52. Drager L.F., Lopes H.F., Maki-Nunes C., et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010, 5:e12065.
53. Drager L.F., Bortolotto L.A., Figueiredo A.C., et al. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007, 131:1379-1386.
54. Drager L.F., Bortolotto L.A., Krieger E.M., Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 2009, 53:64-69.
55. Floras J.S., Hassan M.O., Jones J.V., et al. Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability. J Hypertens 1988, 6:525-535.
56. Floras J.S., Hassan M.O., Jones J.V., et al. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988, 11:273-281.
57. Logan A.G., Perlikowski S.M., Mente A., et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001, 19:2271-2277.
58. Pedrosa R.P., Drager L.F., Genta P.R., et al. Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. Chest 2010, 137:1078-1084.
59. Pedrosa R.P., Drager L.F., Gonzaga C.C., et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011, 58:811-817.
60. Pedrosa R.P., Drager L.F., de Paula L.K., et al. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest 2013, 144:1487-1494.
61. Brooks D., Horner R.L., Kozar L.F., Render-Teixeira C.L., Phillipson E.A. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997, 99:106-109.
62. Marin J.M., Agusti A., Villar I., et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. J Am Med Assoc 2012, 307:2169-2176.
63. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
64. O'Connor G.T., Caffo B., Newman A.B., et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009, 179:1159-1164.
65. Cano-Pumarega I., Duran-Cantolla J., Aizpuru F., et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med 2011, 184:1299-1304.
66. Lloberes P., Lozano L.S., Romero O., et al. Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension. J Sleep Res 2010, 19:597-602.
67. Muxfeldt E.S., Margallo V.S., Guimaraes G.M., Salles G.F. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens 2014, 27:1069-1078.
68. Friedman O., Bradley T.D., Chan C.T., Parkes R., Logan A.G. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension 2010, 56:1077-1082.
69. Nicholl D.D., Hanly P.J., Poulin M.J., et al. Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med 2014, 190:572-580.
70. Kasiakogias A., Tsioufis C., Thomopoulos C., et al. Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up. J Hypertens 2013, 31:352-360.
71. Barbe F., Duran-Cantolla J., Sanchez-de-la-Torre M., et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. J Am Med Assoc 2012, 307:2161-2168.
72. Drager L.F., Bortolotto L.A., Figueiredo A.C., Krieger E.M., Lorenzi-Filho G. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712.
73. Drager L.F., Pedrosa R.P., Diniz P.M., et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 2011, 57:549-555.
74. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68-73.
75. Gottlieb D.J., Punjabi N.M., Mehra R., et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 2014, 370:2276-2285.
76. Robinson G.V., Smith D.M., Langford B.A., Davies R.J., Stradling J.R. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006, 27:1229-1235.
77. Barbe F., Duran-Cantolla J., Capote F., et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010, 181:718-726.
78. Duran-Cantolla J., Aizpuru F., Montserrat J.M., et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomized controlled trial. Br Med J 2010, 341:c5991.
79. Montesi S.B., Edwards B.A., Malhotra A., Bakker J.P. The effect of continuous positive airway pressure treatment on blood pressure: a systemic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 2012, 8:587-596.
80. Alajmi M., Mulgrew A.T., Fox J., et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185:67-72.
81. Bratton D.J., Stradling J.R., Barbe F., Kohler M. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials. Thorax 2014, 69:1128-1135.
82. Haentjens P., Van Meerhaeghe A., Moscariello A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167:757-764.
83. Bazzano L.A., Khan Z., Reynolds K., He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
84. Floras J.S., Bradley T.D. Treating obstructive sleep apnea: is there more to the story than 2 millimeters of mercury?. Hypertension 2007, 50:289-291.
85. Bakker J.P., Edwards B.A., Gautam S.P., et al. Blood pressure improvement with continuous positive airway pressure is independent of obstructive sleep apnea severity. J Clin Sleep Med 2014, 10:365-369.
86. Schein A.S., Kerkhoff A.C., Coronel C.C., Plentz R.D., Sbruzzi G. Continuous positive airway pressure reduces blood pressure in patients with obstructive sleep apnea; a systematic review and meta-analysis with 1000 patients. J Hypertens 2014, 32:1762-1773.
87. Drager L.F., Brunoni A.R., Jenner R., et al. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomized trials. Thorax 2015, 70:258-264.
88. Logan A.G., Tkacova R., Perlikowski S.M., et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21:241-247.
89. Lloberes P., Sampol G., Espinel E., et al. A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea. J Hypertens 2014, 32:1650-1657.
90. Litvin A.Y., Sukmarova Z.N., Elfimova E.M., et al. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag 2013, 9:229-235.
91. Lozano L., Tovar J.L., Sampol G., et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 2010, 28:2161-2168.
92. Iftikhar I.H., Valentine C.W., Bittencourt L.R., et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens 2014, 32:2341-2350.
93. Varounis C., Katsi V., Kallikazaros I.E., et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. Int J Cardiol 2014, 175:195-198.
94. Muxfeldt E.S., Margallo V., Costa L.M., et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension 2015, 65:736-742.
95. Davies R.J., Crosby J., Prothero A., Stradling J.R. Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring, compared with matched control subjects, and their response to treatment. Clin Sci (Lond) 1994, 86:417-424.
96. Shirasaki O., Kuwabara M., Saito M., et al. Development and clinical application of a new technique for detecting 'sleep blood pressure surges' in sleep apnea patients based on a variable desaturation threshold. Hypertens Res 2011, 34:922-928.
97. Cloward T.V., Walker J.M., Farney R.J., Anderson J.L. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003, 124:594-601.
98. Koga S., Ikeda S., Nakata T., Yasunaga T., Maemura K. Effects of nasal continuous positive airway pressure on left ventricular concentric hypertrophy in obstructive sleep apnea syndrome. Intern Med 2012, 51:2863-2868.
99. Nakashima H., Katayama T., Takagi C., et al. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 2006, 27:2317-2322.
100. Kanagala R., Murali N.S., Friedman P.A., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003, 107:2589-2594.
101. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173:910-916.
102. Patel D., Mohanty P., Di Biase L., et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol 2010, 3:445-451.
103. Hoyer F.F., Lickfett L.M., Mittmann-Braun E., et al. High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. J Interv Card Electrophysiol 2010, 29:37-41.